- Home
- CLRB vs LEDS Comparison
CLRB vs LEDS Comparison
Compare CLRB & LEDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRB
- LEDS
- Stock Information
- Founded
- CLRB 2002
- LEDS 2005
- Country
- CLRB United States
- LEDS Taiwan
- Employees
- CLRB N/A
- LEDS 116
- Industry
- CLRB Biotechnology: Pharmaceutical Preparations
- LEDS Semiconductors
- Sector
- CLRB Health Care
- LEDS Technology
- Exchange
- CLRB Nasdaq
- LEDS Nasdaq
- Market Cap
- CLRB 17.6M
- LEDS 17.8M
- IPO Year
- CLRB N/A
- LEDS 2010
- Fundamental
- Price
- CLRB $4.98
- LEDS $2.47
- Analyst Decision
- CLRB Hold
- LEDS
- Analyst Count
- CLRB 2
- LEDS 0
- Target Price
- CLRB N/A
- LEDS N/A
- AVG Volume (30 Days)
- CLRB 1.3M
- LEDS 37.0K
- Earning Date
- CLRB 08-12-2025
- LEDS 07-07-2025
- Dividend Yield
- CLRB N/A
- LEDS N/A
- EPS Growth
- CLRB N/A
- LEDS N/A
- EPS
- CLRB N/A
- LEDS N/A
- Revenue
- CLRB N/A
- LEDS $14,780,000.00
- Revenue This Year
- CLRB N/A
- LEDS N/A
- Revenue Next Year
- CLRB N/A
- LEDS N/A
- P/E Ratio
- CLRB N/A
- LEDS N/A
- Revenue Growth
- CLRB N/A
- LEDS 160.76
- 52 Week Low
- CLRB $4.36
- LEDS $0.92
- 52 Week High
- CLRB $94.50
- LEDS $3.16
- Technical
- Relative Strength Index (RSI)
- CLRB 33.34
- LEDS 45.36
- Support Level
- CLRB $6.50
- LEDS $2.44
- Resistance Level
- CLRB $8.30
- LEDS $2.75
- Average True Range (ATR)
- CLRB 1.42
- LEDS 0.15
- MACD
- CLRB -0.66
- LEDS -0.03
- Stochastic Oscillator
- CLRB 1.63
- LEDS 13.33
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
About LEDS SemiLEDS Corporation
SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.